Plus Therapeutics (PSTV) Cash & Equivalents (2010 - 2026)
Plus Therapeutics (PSTV) reported Cash & Equivalents of $3.0 million for Q1 2026, down 69.37% year-over-year from $9.9 million in Q1 2025, and down 28.99% quarter-over-quarter from $4.3 million in Q4 2025.
Plus Therapeutics (PSTV) Cash & Equivalents (2010 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has 17 years of Cash & Equivalents data on file, last reported at $3.0 million in Q1 2026.
- Cash & Equivalents for Q1 2026 came in at $3.0 million, down 69.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.0 million (down 69.37% YoY), and the FY2025 annual result was $4.3 million, up 5500.0% from the prior year.
- Cash & Equivalents eased to $3.0 million in Q1 2026 per PSTV's latest filing, from $4.3 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $21.2 million in Q1 2022 and troughed at $74000.0 in Q1 2024.
- A 5-year average of $9.4 million and a median of $9.9 million in 2025 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2024 and 2025: Cash & Equivalents sank 99.42% in 2024, then jumped 13233.78% in 2025.
- A 5-year view of Cash & Equivalents shows it stood at $18.1 million in 2022, then tumbled by 52.79% to $8.6 million in 2023, then slumped by 99.11% to $76000.0 in 2024, then surged by 5500.0% to $4.3 million in 2025, then retreated by 28.99% to $3.0 million in 2026.
- Business Quant data shows PSTV's Cash & Equivalents at $3.0 million in Q1 2026, $4.3 million in Q4 2025, and $13.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 1.91 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 2.77 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 18.44 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 7.15 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 5.49 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 558.94 Mn |
| 10 | Plus Therapeutics | 37.48 Mn | 22.37 Mn | - | 3.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.02 Mn |
| Dec 31, 2025 | 4.26 Mn |
| Sep 30, 2025 | 13.29 Mn |
| Jun 30, 2025 | 2.23 Mn |
| Mar 31, 2025 | 9.87 Mn |
| Dec 31, 2024 | 76,000.00 |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 4.91 Mn |
| Mar 31, 2024 | 74,000.00 |
| Dec 31, 2023 | 8.55 Mn |
| Sep 30, 2023 | 11.01 Mn |
| Jun 30, 2023 | 10.90 Mn |
| Mar 31, 2023 | 12.72 Mn |
| Dec 31, 2022 | 18.12 Mn |
| Sep 30, 2022 | 20.27 Mn |
| Jun 30, 2022 | 18.09 Mn |
| Mar 31, 2022 | 21.24 Mn |
| Dec 31, 2021 | 18.40 Mn |
| Sep 30, 2021 | 21.28 Mn |
| Jun 30, 2021 | 17.16 Mn |